Cytiva (formerly GE Life Sciences) Bioprocessing Solutions for Development and Manufacture of Biotherapeutics and Vaccines

Cytiva, provides bioprocessing products and services to the biopharmaceutical industry for the development and manufacture of therapeutics and vaccines.

The company uses its scientific knowledge and technical expertise to help biomanufacturers increase speed-to-market, reduce costs, and improve productivity.

Single-use solutions for bioprocessing

The company provides a wide range of innovative single-use solutions designed to achieve high productivity. Ranging from single-use workflows and biomanufacturing facilities to disposable chromatography columns, the company’s offerings help drive collaboration in the pharmaceutical industry.

Upstream and downstream bioprocessing

Cytiva provides a wide range of integrated products and solutions to meet the needs of the biopharmaceutical industry for upstream and downstream bioprocessing.

Its portfolio includes products for cell culture and fermentation (HyClone™ cell culture media, sera, process liquids, ReadyToProcess WAVE™, Xcellerex™ bioreactors and Xcellerex fermentors), chromatography (ÄKTA™ chromatography system, chromatography columns and resins, and in-line conditioning systems), filtration (tangential flow filtration and ULTA™ normal flow filtration products), and liquid preparation and management (Xcellerex single-use mixers, ReadyKart™ mobile processing stations, ReadyToProcess™ storage bins and assemblies, and ReadyCircuit™ bag assemblies and ReadyMate™ connectors).

Cytiva also offers single-use systems, components, assemblies, and manufacturing facility solutions.

Biomanufacturing design and management for therapies and vaccines

Cytiva offers drug developers an array of biomanufacturing solutions that increase efficiency and optimize productivity. GE’s Enterprise Solutions provide an end-to-end platform for biologics management with innovative, modular solutions for the launch of new molecules, bringing biosimilars to an emerging market, or expanding biomanufacturing capacity to support production needs. Enterprise Solutions provides clients with new options to achieve their biomanufacturing goals.

FlexFactory™ is an integrated, single-use, or hybrid biomanufacturing platform that provides rapid access to current good manufacturing practice (cGMP) manufacturing capacity while providing flexibility.

The KuBio™ facilities and BioPark campus each offer a configurable design space to meet the client’s biomanufacturing needs. These turnkey facility solutions delay capital investment, reduce business risk, and improve speed-to-market.

Fast Trak biomanufacturing services

Cytiva provides a wide range of Fast Trak™ support services for drug development applications, including increasing existing capacity, launching a new molecule, and bringing biosimilars to market. The company helps manufacturers stay competitive and maintain high speed-to-market.

Performed with open collaboration and transparency, the company offers services to support cell culture medium development, upstream and downstream process development, clinical manufacturing, analytical development, quality control, and process transfer.

Cytiva’s Fast Trak portfolio supports quick development from molecule to market, ensuring market approval is reached in as short a time and as cost-effectively as possible. The company also accelerates outcomes, mitigates risks and conducts its processes with full transparency to meet its clients’ needs.

In addition, Cytiva offers education courses globally for practical, hands-on bioprocess training. Fast Trak courses are offered at nine locations worldwide, in addition to on-demand courses.

Bioprocess security of supply

Higher productivity, purity, and yield have been the driving forces when designing manufacturing processes for biopharmaceuticals.

The choices you make today will impact your manufacturing process for several years ahead.

For the development of an optimised process and for consistent and cost-effective biopharmaceutical production, a close collaboration between the manufacturer and its supplier is beneficial.

Cytiva offers products, services and support to assist you throughout your product’s lifecycle.

Make an enquiry

Press Release

GEHC and NIBRT to Enhance Talent Growth in Single-Use Bioprocessing

GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are partnering to combine their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing.

Product and Services
White Papers

Chasing the Biopharma Market: From New Customer Bases and Vaccines to Biosimilars and Antibodies

What are the emerging trends and hot topics in biopharma, and how can companies take advantage of them in order to succeed?

GE Healthcare Bio-Sciences AB - Sweden

Bjorkgatan 30

SE-75184 Uppsala


+ 46 771 400 600 + 46 18 612 19 10

Cytiva (formerly GE Life Sciences) Images

Press Release

20 November 2019

Akeso Pharmaceuticals, a biotech company that focuses in the growth and commercialisation of innovative biologics, will open a facility in Guangzhou, China, based on GE Healthcare Life Sciences’ FlexFactory platform, intended for proficient and cost-effective production of recombinant biologics.

Read more
19 September 2019

GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are partnering to combine their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing.

Read more
28 March 2019

Visit GE Healthcare at booth #3141 to accelerate your bioprocess journey.

Read more
19 September 2018

Since she was a child, Therése Kallur has been interested in how the mind works. Today, she makes spare parts for it.

Read more
4 September 2018

The Swedish Government and GE Healthcare are opening Testa Center, an innovation centre in Uppsala, Sweden, to boost the commercialisation of new technologies and support manufacturing capabilities in the life sciences sector.

Read more
8 February 2018

Clover Biopharmaceuticals has chosen GE Healthcare’s biomanufacturing platform FlexFactory for its new facility located in Changxing, Zhejiang, China.

Read more
5 December 2017

United BioPharma (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility focusing on late-stage clinical and commercial production capacity of therapeutic monoclonal antibodies in Hsinchu Industrial Park, Taiwan.

Read more
28 November 2017

GE has completed a strategic minority investment in Irish-owned Zenith Technologies, a leading technology company delivering manufacturing software systems and solutions for the life sciences industry.

Read more
21 November 2017

GE Healthcare Life Sciences has announced a $7m expansion project at its single-use technology manufacturing facility in Westborough, US.

Read more
14 November 2017

GE Healthcare has announced that Dr. Reddy’s Laboratories will be installing India’s first-ever FlexFactory, a single-use manufacturing platform to expand the biologics production capacity at its facility in Hyderabad, India.

Read more

Regional Offices

GE Healthcare Bio-Sciences AB - Sweden

Bjorkgatan 30

SE-75184 Uppsala


+ 46 771 400 600 + 46 18 612 19 10
GE Healthcare Europe GmbH - Germany

Munzinger Strasse 5

D-79111 Freiburg


+49 0800 9080 711 +49 0800 9080 712
GE Healthcare UK Limited - UK

Amersham Place

Little Chalfont



United Kingdom

+44 0800 515 313 +44 0800 616 927
GE Healthcare Bio-Sciences Corp. - USA

100 Results Way

Marlborough, MA


United States of America

+ 1 800 526 3593 + 1 877 295 8102
GE Healthcare Japan Corporation - Japan

Sanken Bldg.3-25-1

Hyakunincho Shinjuku-ku

Tokyo 169-0073


+ 81 3 5331 9336 + 81 3 5331 9370

Go Top